Quotes for Ziccum AB
- +/-
- %
- ()
Board
CEO
- Göran Conradsson
Chairperson of the Board
- Fredrik Sjövall
Board
- Kristian Kierkegaard
- Mattias Münnich
- Mikaela Bruhammar
- Ola Camber
Ziccum is a Swedish pharmaceutical company that develops new preparations of biological drugs. With their patented technology, LaminarPace, the company develops dry preparations of products currently only available in liquid form. The company is based in Lund.
News
- Spotlight: Market Notice 280/20 – Ziccum AB will be delisted after close of the market on November 30, 2020
- Ziccum AB genomför listbyte till Nasdaq First North Growth Market och offentliggör bolagsbeskrivning
- Ziccum AB carries out list change to Nasdaq First North Growth Market and releases company description
- ZICCUM AB Delårsrapport 1 januari-30 september 2020
- ZICCUM AB interim report January 1-September 30, 2020
Analysis
- Penser Research: Ziccum: En teknologi på en marknad med hela världens fokus - Penser
- Penser Research: Ziccum: Stort steg framåt med nytt samarbete - Penser
- Penser Research: Ziccum: Nyheter kring samarbeten att vänta 2020 - Penser
- Penser Research: Ziccum: Eliminera kylkedjan för vaccin - Penser
- SvD Börsplus: Riskabel resa från vått till torrt